Insulin aspart, recombinant Subcutaneous and Pipracil
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pipracil and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: penicillin v potassium
Brand name: PC Pen VK, Pen-V, Penicillin-VK, Veetids
Synonyms: Penicillin, Penicillin V Potassium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Piqray
- Insulin aspart, recombinant Subcutaneous-Piqray 200MG Daily Dose
- Insulin aspart, recombinant Subcutaneous-Piqray 250MG Daily Dose
- Insulin aspart, recombinant Subcutaneous-Piqray 300MG Daily Dose
- Insulin aspart, recombinant Subcutaneous-Pirbuterol Inhalation
- Insulin aspart, recombinant Subcutaneous-Pirfenidone
- Pipracil-Insulin degludec
- Pipracil-Insulin Degludec (U-100) Prefilled Pens
- Pipracil-Insulin Degludec (U-100) Vials
- Pipracil-Insulin Degludec (U-200) Prefilled Pens
- Pipracil-Insulin degludec and liraglutide
- Pipracil-Insulin degludec and liraglutide Subcutaneous